A phase 2 study of SCY-078 in combination with Isavuconazole, an azole used to treat the subjects with Invasive Pulmonary Aaspergillosis (IPA).
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2018
At a glance
- Drugs SCY 078 (Primary)
- Indications Aspergillosis
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2018 New trial record
- 04 Jan 2018 According to a SCYNEXIS media release, company plans to intiate this trial in third quarter 2018.